Global Market Study on Clinical Trial Management System - Asia to Witness Highest Growth by 2019

Submitted by: Submitted by

Views: 10

Words: 4040

Pages: 17

Category: Business and Industry

Date Submitted: 08/03/2015 03:37 AM

Report This Essay

Global Market Study on Clinical Trial Management System - Asia to

Witness Highest Growth by 2019

Persistence Market Research

Global Clinical Trial Management System

Market Will Reach $1,848.5 million in 2019 :

Persistence Market Research

Persistence Market Research

1

Global Market Study on Clinical Trial Management System - Asia to

Witness Highest Growth by 2019

Persistence Market Research Released New Market Report “Global Market Study on Clinical

Trial Management System: Asia to Witness Highest Growth by 2019” the global

clinical trial management system market was valued at USD 844.0 million in 2013 and is

expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD

1,848.5 million in 2019.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/clinical-trialmanagement-system-market.asp

Clinical trial is a medical research study performed on humans to check the safety and

efficacy of drugs, devices and therapeutic products before they are finally launched in the

market. Globally, the CTMS market is witnessing significant growth due to increasing R&D

investment in pharmaceutical, life science and clinical research industries. It empowers

organizations and research centers to enhance productivity and effectiveness of clinical

trials by advancing and managing clinical trials. Integration of CTMS with hospital

information system (HIS) provides more accurate and time saving documentation is also

driving growth for the CTMS market. Additionally, increasing prevalence of diseases is

supporting clinical trials in different regions, and increased clinical research outsourcing is

playing a major role in the growth of the CTMS market. Increasing regulatory requirements in

many countries has resulted in increased complexity for clinical trial protocols. Presence of

various end users such as pharmaceuticals, clinical research organizations (CRO) and

healthcare providers has increased the acceptance of CTMS. The global CTMS...